Dennis H. Giesing - Jun 16, 2022 Form 4 Insider Report for Immunome Inc. (IMNM)

Role: Chief Development Officer
Signature: /s/ Purnanand D. Sarma, Attorney-in-Fact
Stock symbol: IMNM
Transactions as of: Jun 16, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/21/2022, 06:05 PM
Previous filing: Jun 1, 2021
Next filing: Jun 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMNM	Stock Option (Right to Buy)	Award	$0	+60K		$0.00	60K	Jun 16, 2022	Common Stock	60K	$3.42	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	With respect to the options to purchase 30,000 shares, 25% of the shares subject to such options vest on June 16, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to such options shall vest every month thereafter. With respect to the remaining options to purchase 30,000 shares, 50% of the shares subject to such options vest on June 16, 2023, and the remaining 50% of the shares subject to such options vest on June 16, 2024.

Content

With respect to the options to purchase 30,000 shares, 25% of the shares subject to such options vest on June 16, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to such options shall vest every month thereafter. With respect to the remaining options to purchase 30,000 shares, 50% of the shares subject to such options vest on June 16, 2023, and the remaining 50% of the shares subject to such options vest on June 16, 2024.